PMID: 41547240

Multi-target incretin-based therapeutics: The rise of dual and triple agonists for metabolic disorders.

Alavi Seyed Ebrahim, Boshrouyeh Reza, Raza Aun, Ebrahimi Shahmabadi Hasan

European journal of medicinal chemistry · 2026

Vol. 305, pp. 118587

View on PubMedDOI

This entry links to third-party literature. For research use only.

HumansIncretinsMetabolic DiseasesDiabetes Mellitus, Type 2AnimalsGlucagon-Like Peptide 1Hypoglycemic Agents

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.